Finance

Beta
Lists
950210:KRX
Prestige Biopharma Ltd
₩6,960.00
+6.42%
(+420.00) 1D
Jun 12, 3:30:05 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 950210...
Open
₩6,540
High
₩6,990
Low
₩6,540
Mkt. cap
418.27B
Avg. vol.
103.84K
Volume
0.00
52-wk high
₩20,000
52-wk low
₩6,140
EPS
-₩1,017
Shares outstanding
60.10M
No. of employees
66
Open
₩6,540
High
₩6,990
Low
₩6,540
Mkt. cap
418.27B
Avg. vol.
103.84K
Volume
0.00
52-wk high
₩20,000
52-wk low
₩6,140
EPS
-₩1,017
Shares outstanding
60.10M
No. of employees
66
News stories
From sources across the web
About Prestige Biopharma Ltd
CEO-
Employees66
Founded2015
Headquarters-
SectorBiotechnology
Websiteprestigebiopharma.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.53B
2.36B
7.81B
509.20M
Cost of goods sold
26.56B
2.23B
10.17B
12.23B
Cost of revenue
26.56B
2.23B
10.17B
12.23B
Research and development expenses
19.12B
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-38.53B
24.95B
16.79B
14.63B
Operating expense
-7.49B
24.95B
16.79B
14.63B
Total operating expenses
19.08B
27.18B
26.96B
26.86B
Operating income
-13.55B
-24.82B
-19.15B
-26.35B
Other non operating income
-58.89B
4.06B
-1.38B
-3.05B
EBT including unusual items
-9.32B
-20.76B
-20.53B
-29.40B
EBT excluding unusual items
-68.78B
-20.76B
-20.53B
-29.40B
Income tax expense
-229.95M
-69.96M
-17.84M
-20.29M
Effective tax rate
2.47%
0.34%
0.09%
0.07%
Other operating expenses
520.59M
-
-
-
Net income
-8.78B
-12.62B
-15.37B
-20.56B
Net profit margin
-158.81%
-534.55%
-196.66%
-4,037.83%
Earnings per share
-
-
-
-
Interest and investment income
9.14B
-
-
-
Interest expense
-7.63B
-
-
-
Net interest expenses
1.51B
-
-
-
Depreciation and amortization charges
8.61B
-
-
-
EBITDA
-8.10B
-19.37B
-13.70B
-20.90B
Gain or loss from assets sale
6.70M
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer